Ready for Answers?

The Isolate test panels give healthcare providers a new diagnostic tool to confirm suspected diagnoses across three medical disciplines – neurology, gastroenterology, and rheumatology.

This new process identifies disease much sooner than traditional diagnostic methods, which can take months to years. By confirming the suspected autoimmune disease sooner, doctors can initiate treatment early in the disease progression to slow the illness and allow better management of its long-term physical, emotional, and financial effects.

IQuity’s Isolate tests are now being introduced for use by providers.

IsolateMS® – Available – Order a Test
IsolateIBS-IBD® – Available – Order a Test
IsolateFibromyalgia® – Available – Order a Test

These tests will support providers in earlier diagnosis of conditions such as:

  • Multiple Sclerosis
  • IBS
  • Crohn’s Disease
  • Ulcerative Colitis
  • Fibromyalgia
  • Lupus
  • Rheumatoid Arthritis
  • Other challenging autoimmune diseases and related conditions

Please subscribe to IQuity Insights to stay up-to-date on our test release dates and new research efforts underway.

Subscribe Now

Review Our Research

IQIsolate MS logo

IQuity is committed to transparency and openly sharing our research. Our News & Resources section contains peer-reviewed journal articles, white papers, and other information we hope you find helpful.

Learn More

RNA-based diagnostics have the capability of providing highly accurate information that improves patient stratification. Measurements of RNA allow us to uncover a snapshot of gene activity in real time enabling providers to identify disease earlier than ever before. It is generally accepted that patients who get the right treatment sooner have improved long-term outcomes.

IQuity is firmly committed to data transparency, and we invite you to review our scientific peer-reviewed papers.

Dr. Tom Aune

Review Peer-Reviewed Articles at